Pathophysiology and management of saphenous vein graft disease
- 3 August 2023
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 21 (8) , 565-572
Abstract
Introduction The saphenous vein graft (SVG) is the most used conduit in CABG. With standardization of its use as a conduit came an understanding of its accelerated atherosclerosis, known as saphenous vein graft disease (SVGD). Given its extensive use, a review of the pathophysiology and management of SVGD is important as we optimize its use. Areas Covered For this review, an extensive literature search was completed to identify and examine the evolution of SVG in CABG, mechanisms driving SVGD, and methods developed to prevent and manage it. This includes a review of relevant major papers and trials in this space. Expert Opinion Eras of evolution in SVG usage in CABG include an experimental era, era of SVG dominance in CABG, and the current era of mixed venous and arterial grafting. As SVGD was studied, the mechanisms behind it became more understood, and prevention and management methods were developed. As advances in surgical techniques and pharmacotherapy continue to reduce occurrence and severity of SVGD, long-term patency of SV grafts continues to improve and remain excellent in optimized settings. With continued innovation and improvement in operative techniques, the SVG conduit is and will remain an important player in the field of coronary bypass.Keywords
This publication has 65 references indexed in Scilit:
- Expandable external support device to improve Saphenous Vein Graft Patency after CABGJournal of Cardiothoracic Surgery, 2013
- Conduits for Coronary Bypass: Vein GraftsThe Korean Journal of Thoracic and Cardiovascular Surgery, 2012
- Off-Pump Coronary Artery Bypass Surgery Is Associated With Worse Arterial and Saphenous Vein Graft Patency and Less Effective RevascularizationCirculation, 2012
- Pathology of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft LesionsJACC: Cardiovascular Interventions, 2012
- Saphenous Vein Grafts With Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass SurgeryCirculation, 2011
- The history of the in situ saphenous vein bypassJournal of Vascular Surgery, 2011
- Mechanical Stretch and Intimal HyperplasiaArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgeryJACC, 2004
- Prostacyclin release from the human saphenous vein in diabetics is lower than in nondiabeticsWorld Journal of Surgery, 1992
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986